fda compounding semaglutide enforcement news november 2025 pharmacies to halt sales May 22 Compounded weight loss drugs get

Some research suggests that GLP-1 agonists may have anti-inflammatory effects that could theoretically influence the autoimmune process itself, though this remains speculative and has not been demonstrated in clinical trials specifically for thyroid autoimmunity

A major policy change is now emerging for Medicare

Some patients find that lower doses (e.g., 1.7 mg) work well for sustaining results with fewer side effects

Retatrutide is still an investigational compound, not an approved commercial medicine currently available to the public in Australia

Given the impairment in DPP4i action evident in HFD-fed mice, we wondered whether DPP-4 inhibition retained its hypolipidemic actions in older mice